Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 14, 2019

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.

Latest News

Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number

December 4, 2019

Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility

October 10, 2019

Ampio Retains Legal Counsel for Transaction Advisory Committee

September 18, 2019
member-logo-85

© 2020 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Clinical Trial
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us